FIGS (NYSE:FIGS) Stock Price Up 4.7%

Shares of FIGS, Inc. (NYSE:FIGS) were up 4.7% on Wednesday . The company traded as high as $4.66 and last traded at $4.65. Approximately 1,930,331 shares were traded during trading, a decline of 47% from the average daily volume of 3,642,981 shares. The stock had previously closed at $4.44.

Analyst Ratings Changes

A number of research analysts have weighed in on FIGS shares. Barclays cut their price objective on shares of FIGS from $7.00 to $5.00 and set an “equal weight” rating on the stock in a research report on Friday, March 1st. Roth Mkm cut their price objective on shares of FIGS from $7.50 to $6.75 and set a “buy” rating on the stock in a research report on Friday, May 10th. Bank of America reiterated an “underperform” rating and set a $4.50 price objective (down previously from $8.50) on shares of FIGS in a research report on Tuesday, April 2nd. The Goldman Sachs Group lowered their target price on shares of FIGS from $4.85 to $4.25 and set a “sell” rating for the company in a research note on Tuesday, April 23rd. Finally, Oppenheimer lowered shares of FIGS from an “outperform” rating to a “market perform” rating in a research note on Friday, March 8th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $5.30.

FIGS Stock Down 0.6 %

The stock has a market capitalization of $885.20 million, a PE ratio of 47.60, a price-to-earnings-growth ratio of 64.27 and a beta of 1.42. The stock’s 50 day moving average price is $5.17 and its 200-day moving average price is $5.64.

FIGS (NYSE:FIGS) last released its quarterly earnings data on Thursday, May 9th. The company reported $0.01 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.02. FIGS had a net margin of 4.07% and a return on equity of 6.12%. The company had revenue of $119.29 million during the quarter, compared to analyst estimates of $117.38 million. During the same period in the prior year, the firm earned $0.01 earnings per share. The firm’s revenue for the quarter was down .8% compared to the same quarter last year. As a group, sell-side analysts predict that FIGS, Inc. will post 0.03 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Heather L. Hasson sold 28,614 shares of the company’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $4.89, for a total value of $139,922.46. Following the completion of the sale, the insider now directly owns 468,870 shares of the company’s stock, valued at $2,292,774.30. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders sold a total of 31,644 shares of company stock valued at $155,648 over the last three months. 22.30% of the stock is owned by company insiders.

Institutional Trading of FIGS

Several hedge funds have recently modified their holdings of FIGS. Banque Cantonale Vaudoise lifted its position in shares of FIGS by 50.0% during the first quarter. Banque Cantonale Vaudoise now owns 6,000 shares of the company’s stock valued at $30,000 after buying an additional 2,000 shares during the last quarter. Octavia Wealth Advisors LLC acquired a new position in shares of FIGS during the fourth quarter valued at about $75,000. International Assets Investment Management LLC acquired a new position in shares of FIGS during the fourth quarter valued at about $76,000. Janney Montgomery Scott LLC acquired a new position in shares of FIGS during the third quarter valued at about $78,000. Finally, Counterpoint Mutual Funds LLC acquired a new position in shares of FIGS during the fourth quarter valued at about $90,000. 92.21% of the stock is owned by hedge funds and other institutional investors.

FIGS Company Profile

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.